참고문헌
- Akman RY, Koseoglu H, Oguzulgen AI, et al (2014). Prostate Biopsy in the Elderly: Histologic Findings and Treatment Necessity. Asian Pac J Cancer Prev, 15, 8937-9. https://doi.org/10.7314/APJCP.2014.15.20.8937
- Albasri A, El-Siddig A, Hussainy A, et al (2014). Histopathologic characterization of prostate diseases in Madinah, Saudi Arabia. Asian Pac J Cancer Prev, 15, 4175-9. https://doi.org/10.7314/APJCP.2014.15.10.4175
- Anderson-Jackson L, McGrowder DA, Alexander-Lindo R (2012). Prostate specific antigen and gleason score in men with prostate cancer at a private diagnostic radiology centre in Western Jamaica. Asian Pac J Cancer Prev, 13, 1453-6. https://doi.org/10.7314/APJCP.2012.13.4.1453
- Arafa MA, Rabah DM, Wahdan IH (2012). Awareness of general public towards cancer prostate and screening practice in arabic communities: a comparative multi-center study. Asian Pac J Cancer Prev, 13, 4321-6. https://doi.org/10.7314/APJCP.2012.13.9.4321
- Boyle P, Severi G, Giles GG (2003). The epidemiology of prostate cancer. Urol Clin North Am, 30, 209-17. https://doi.org/10.1016/S0094-0143(02)00181-7
- Burford DC, Kirby M, Austoker A (2010). Prostate cancer risk management programme information for primary care; PSA testing in asymptomatic men. evidence document. NHS Cancer Screening Programmes, 143-213.
- Cihan YB, Arslan A, Ergul MA (2013). Subtypes of white blood cells in patients with prostate cancer or benign prostatic hyperplasia and healthy individuals. Asian Pac J Cancer Prev, 14, 4779-83. https://doi.org/10.7314/APJCP.2013.14.8.4779
- Dwivedi S, Goel A, Natu SM, et al (2011). Diagnostic and prognostic significance of prostate specific antigen and serum interleukin 18 and 10 in patients with locally advanced prostate cancer: a prospective study. Asian Pac J Cancer Prev, 12, 1843-8.
- Felgueiras J, Silva JV, Fardilha M (2014). Prostate cancer: the need for biomarkers and new therapeutic targets. J Zhejiang Univ Sci B, 15, 16-42. https://doi.org/10.1631/jzus.B1300106
- Ferlay J, Parkin DM, Steliarova-Foucher E (2010). Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer, 46, 765-81. https://doi.org/10.1016/j.ejca.2009.12.014
- Grivas N, Hastazeris K, Kafarakis V, et al (2012). Prostate cancer epidemiology in a rural area of north Western Greece. Asian Pac J Cancer Prev, 13, 999-1002. https://doi.org/10.7314/APJCP.2012.13.3.999
- Heidenreich A, Bastian PJ, Bellmunt J, et al (2014). EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol, 65, 124-37. https://doi.org/10.1016/j.eururo.2013.09.046
- Humphrey (2004). Gleason grading and prognostic factors in carcinoma of the prostate. Modern Pathology, 17, 292-306. https://doi.org/10.1038/modpathol.3800054
- Ismail SI, Soubani M, Nimri JM, Al-Zeer AH (2013). Cancer incidence in Jordan from 1996 to 2009-A comprehensive study. Asian Pac J Cancer Prev, 14, 3527-34. https://doi.org/10.7314/APJCP.2013.14.6.3527
- Jemal A, Siegel R, Xu J, et al (2010). Cancer statistics. CA Cancer J Clin, 60, 277-300. https://doi.org/10.3322/caac.20073
- Kash DP, Lal M, Hashmi AH, et al (2014). Utility of digital rectal examination, serum prostate specific antigen, and transrectal ultrasound in the detection of prostate cancer: a developing country perspective. Asian Pac J Cancer Prev, 15, 3087-91. https://doi.org/10.7314/APJCP.2014.15.7.3087
- Madu CO, Lu Y (2010). Novel diagnostic biomarkers for prostate cancer. J Cancer, 6, 150-77.
- Mosli HA, Abdel-Meguid TA, Al-Maghrabi JA, et al (2009). The clinicopathologic patterns of prostatic diseases and prostate cancer in Saudi patients. Saudi Med J, 30, 1439-43.
- Nasseri K, Mills PK, Allan M (2007). Cancer incidence in the middle Eastern population of California, 1988-2004. Asian Pac J Cancer Prev, 8, 405-11.
- Nelson WG, De Marzo AM, Isaacs WB (2003). Mechanisms of disease prostate cancer. N Engl J Med, 349, 366-81. https://doi.org/10.1056/NEJMra021562
- Rashid R, Mubarak M, Kazi J (2013). Frequency of adenocarcinoma in transrectal ultrasound-guided prostate needle biopsies in men with clinical suspicion of prostate cancer and raised serum prostate specific antigen. Middle East J Cancer, 4, 73-8.
- Salim EI, Moore MA, Al-Lawati JA, et al (2009). Cancer epidemiology and control in the arab world-past, present and future. Asian Pac J Cancer Prev, 10, 3-16.
- Shamseddine A, Saleh A, Charafeddine M, et al (2014). Cancer trends in Lebanon: a review of incidence rates for the period of 2003-2008 and projections until 2018. Popul Health Metr, 12, 4. https://doi.org/10.1186/1478-7954-12-4
- Shariat SF, Roehrborn CG (2008). Using biopsy to detect prostate cancer. Rev Urol, 10, 262-80.
- Verim L, Yildirim A, Basok EK, et al (2013). Impact of PSA and DRE on histologic findings at prostate biopsy in Turkish Men over 75 years of age. Asian Pac J Cancer Prev, 14, 6085-8. https://doi.org/10.7314/APJCP.2013.14.10.6085
- Yang B, Chen WH, Wen XF, et al (2013). Role of DNA repairrelated gene polymorphisms in susceptibility to risk of prostate cancer. Asian Pac J Cancer Prev, 14, 5839-42. https://doi.org/10.7314/APJCP.2013.14.10.5839
- Zheng X-Y, Zhang P, Xie L-P, et al (2012). Prostate specific antigen velocity (PSAV) and PSAV per initial volume (PSAVD) for early detection of prostate cancer in Chinese men. Asian Pac J Cancer Prev, 13, 5529-33. https://doi.org/10.7314/APJCP.2012.13.11.5529
- Zorlu F, Zorlu R, Divrik RT, et al (2014). Prostate cancer incidence in Turkey: an epidemiological study. Asian Pac J Cancer Prev, 15, 9125-30. https://doi.org/10.7314/APJCP.2014.15.21.9125